Multaq label

Multaq

Multaq Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Multaq Manufacturers

  • Multaq | Air Source Industries Inc
    No Recall

    Multaq | Air Source Industries Inc

    Multaq | Air Source Industries Inc

    There is currently no dosage information available for this product. We apologize for any inconvenience.

  • Physicians Total Care, Inc.
    Multaq | Physicians Total Care, Inc.
    No Recall

    Multaq | Physicians Total Care, Inc.

    Multaq | Physicians Total Care, Inc.

    The recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be taken as one tablet with the morning meal and one tablet with the evening meal.

    Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine, disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole) must be stopped before starting MULTAQ [see Contraindications (4)].

  • Sanofi-aventis U.s. Llc
    Multaq | Sanofi-aventis U.s. Llc
    No Recall

    Multaq | Sanofi-aventis U.s. Llc

    Multaq | Sanofi-aventis U.s. Llc

    The recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be taken as one tablet with the morning meal and one tablet with the evening meal.

    Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine, disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole) must be stopped before starting MULTAQ [see Contraindications (4)].